Article Information
History
- May 27, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Mark Lambiris, PhD1,2,*,
- Guy Ndongala, MPH3,
- Richard Ssempala, MA5,
- Victor Balogun, MSc4,
- Michael Musiitwa, MPH7,
- Fred Kagwire, MPH7,
- Oluseyi Olosunde, MSc8,
- Emmanel Emedo, MD8,
- Sylvie Luketa, MD9,
- Moulaye Sangare, MD9,
- Valentina Buj, MPH1,10,
- Giulia Delvento, MSc1,2,
- Katya Galactionova, PhD2,
- Jean Okitawutshu, MPH1,2,3,
- Antoinette Tshefu, PhD3,
- Elizabeth Omoluabi, PhD4,
- Phyllis Awor, PhD5,
- Aita Signorell, PhD1,2,
- Manuel W. Hetzel, PhD1,2,
- Tristan T. Lee, MSc1,2,
- Nina C. Brunner, MSc1,2,
- Nadja Cereghetti, MSc1,2,
- Theodoor Visser, MA6,
- Harriet G. Napier, MSPH6,
- Christian Burri, PhD1,2,# and
- Christian Lengeler, PhD1,2,#
- 1Swiss Tropical and Public Health Institute, Basel, Switzerland
- 2University of Basel, Basel, Switzerland
- 3Kinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo
- 4Akena Associates, Abuja, Nigeria
- 5Makerere University School of Public Health, Kampala, Uganda
- 6Clinton Health Access Initiative, Boston, MA, USA
- 7UNICEF, Uganda
- 8UNICEF, Nigeria
- 9UNICEF, Democratic Republic of Congo
- 10UNICEF, New York, USA
- ↵*Corresponding author: Dr Mark Lambiris, Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland, tel. +41 61 284 87 33, email: mark.lambiris{at}swisstph.ch
↵# Equal contribution
Posted May 27, 2022.
Real world costs and barriers to the successful implementation of rectal artesunate as pre-referral treatment for severe malaria in Sub-Saharan Africa
